Maastricht UMC, led by Professor Bert Smeets, started a first clinical study in which healthy stem cells from patients with a hereditary disease were added to the patient’s blood.

Healthy, own stem cells that the patient already has naturally in the muscles and that are therefore not rejected by the body. Maastricht UMC is working on a new stem cell therapy for patients with a hereditary disease. For the first time, healthy endogenous stem cells will be used for the recovery of muscle mass.